claim: nhs patients to receive life-saving covid-19 treatments that could cut hospital time by 10 days.
evidence_1: tocilizumab will be used to further reduce mortality from covid-19 and in addition to dexamethasone, which is already standard of care for hospitalised patients receiving supplemental oxygen.", "for patients needing oxygen, it cut the risk of death from 25% to 20%.", "patients in intensive care units across the uk are to receive potentially life-saving treatments for covid-19 government ensures life-saving drugs will be available in nhs healthcare settings with immediate effect patients across the uk who are admitted to intensive care units due to covid-19 are set to receive new life-saving treatments which can reduce the time spent in hospital by up to 10 days, the government has announced yesterday (thursday 7 january).", 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  "published 7 january 2021 from: department of health and social care patients in intensive care units across the uk are to receive potentially life-saving treatments for covid-19 government ensures life-saving drugs will be available in nhs healthcare settings with immediate effect patients across the uk who are admitted to intensive care units due to covid-19 are set to receive new life-saving treatments which can reduce the time spent in hospital by up to 10 days, the government has announced today (thursday 7 january)."
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  )